Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Clinical trial NCT00150995 · COMPLETED

Trial details

NCT number: NCT00150995
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2001-05-01
Primary completion: 2003-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.